Therapeutic challenge of premalignant and malignant skin lesions.
D000085:Acetates / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001446:Balanitis / Q000601:surgery; D001913:Bowen's Disease / Q000601:surgery; D007464:Clioquinol / Q000627:therapeutic use; D003452:Cryosurgery; D003882:Dermatomyositis / Q000188:drug therapy; D004599:Electric Stimulation Therapy; D004598:Electrosurgery; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007642:Keratosis / Q000188:drug therapy / Q000628:therapy; D007911:Lentigo / Q000532:radiotherapy / Q000601:surgery; D007971:Leukoplakia / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011230:Precancerous Conditions / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D007724:Vulvar Lichen Sclerosus / Q000188:drug therapy
D000085:Acetates; D000305:Adrenal Cortex Hormones; D007464:Clioquinol; D005472:Fluorouracil; D006854:Hydrocortisone